XR Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

XR Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,300	Closed	-$3.69M	–	468
2023 Q4	$3.69M	Buy	+41,300	New	+$3.07M	0.14%	62
2023 Q2	–	Sell	-7,500	Closed	-$572K	–	475
2023 Q1	$572K	Buy	+7,500	New	+$622K	0.01%	244
2022 Q3	–	Sell	-17,000	Closed	-$11K	–	482
2022 Q2	$11K	Buy	+17,000	New	+$1.28M	﹤0.01%	335
2020 Q2	–	Sell	-19,600	Closed	-$104K	–	322
2020 Q1	$104K	Sell	19,600 -15,400	-44%	-$1.36M	0.01%	138
2019 Q4	$143K	Buy	+35,000	New	+$3.03M	0.02%	140
2019 Q1	–	Sell	-38,200	Closed	-$6K	–	434
2018 Q4	$6K	Buy	38,200 +15,900	+71%	+$1.28M	﹤0.01%	300
2018 Q3	$7K	Buy	+22,300	New	+$2.16M	﹤0.01%	338

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

XR Securities's XBI Position: Q3 2024 in Review

XR Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 5,872 shares — an estimated $577K sold.

XR Securities first reported a position in XBI in Q4 2018 and held it in 16 quarters. The position peaked at $2.22M in Q3 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

XR Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
XR Securities sold 5,872 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $577K.
XR Securities first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 16 quarters.
XR Securities's State Street SPDR S&P Biotech ETF position peaked at $2.22M in Q3 2022.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on XR Securities's 13F filing for Q3 2024, filed 25 Oct 2024.